Vanda Pharmaceuticals
VNDA
#8239
Rank
ยฃ0.23 B
Marketcap
ยฃ3.88
Share price
-3.36%
Change (1 day)
10.91%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -ยฃ0.12 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.21 Billion. In 2025 the company made an earning of -ยฃ0.12 Billion a decrease over its 2024 earnings that were of -ยฃ30.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ0.12 Billion5.32%
2025 -ยฃ0.12 Billion271.79%
2024 -ยฃ30.45 Million191.43%
2023 -ยฃ10.45 Million-320.45%
2022 ยฃ4.73 M-84.99%
2021 ยฃ31.56 M54.8%
2020 ยฃ20.39 M19.42%
2019 ยฃ17.07 M4.93%
2018 ยฃ16.27 M-228.6%
2017 -ยฃ12.66 Million-8.98%
2016 -ยฃ13.91 Million-53.79%
2015 -ยฃ30.09 Million-30.18%
2014 -ยฃ43.1 Million173.08%
2013 -ยฃ15.78 Million-25.33%
2012 -ยฃ21.14 Million163.61%
2011 -ยฃ8.02 Million-221.15%
2010 ยฃ6.61 M-124.53%
2009 -ยฃ26.98 Million-29.44%
2008 -ยฃ38.24 Million-36.2%
2007 -ยฃ59.93 Million21.81%
2006 -ยฃ49.2 Million170.55%
2005 -ยฃ18.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.45 B-16,300.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ11.81 B-9,942.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ7.92 B-6,704.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.30 B-19,508.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.84 B-8,301.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ7.18 B-6,084.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-ยฃ2.11 Million-98.25%๐Ÿ‡บ๐Ÿ‡ธ USA